RIL acquires 22.8 mn shares of Strand Life Sciences for Rs 393 crs – Business Standard
Reliance Strategic Business Ventures, a wholly-owned subsidiary of Reliance Industries (RIL), announced the acquisition of 22.8 million equity shares of Rs 10 each of Strand Life Sciences for a con…
